Trial Profile
A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Aug 2017
Price :
$35
*
At a glance
- Drugs Pascolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Abbott Biotherapeutics Corp
- 17 Aug 2017 New trial record